Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Positron Emission Tomography and Computed Tomography- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Positron Emission Tomography and Computed Tomography- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 105 Pages

Report ld: 3883741

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Positron Emission Tomography and Computed Tomography was estimated to be worth US$ 1953 million in 2024 and is forecast to a readjusted size of US$ 5065 million by 2031 with a CAGR of 14.8% during the forecast period 2025-2031.

Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its organs. It is suitable for whole body or local tumor examination, Cardiovascular system examination and brain nervous system examination. PET/CT can complete two image scans at the same time. PET images are molecular images of cell metabolism, showing the functional status of cells and organs, but cannot accurately locate the specific anatomical structure of diseased tissues. CT images are structural imaging, which can effectively display the anatomical structure of the human body. PET/CT combines the functional imaging of PET with the images of CT anatomical structure imaging, giving full play to their respective advantages, and has unique value in the qualitative and localization diagnosis of tumors, clinical staging, evaluation of curative effect, finding of metastases and monitoring of recurrence. .

Positron Emission Tomography and Computed Tomography Market Size(US$)

M= millions and B=billions

North American market for Positron Emission Tomography and Computed Tomography was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Positron Emission Tomography and Computed Tomography was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Positron Emission Tomography and Computed Tomography was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Positron Emission Tomography and Computed Tomography include GE Healthcare, Siemens Healthcare, Philips Healthcare, Canon Medical, Neusoft Medical, United Imaging, Arrays Medical, Minfound Medical, Sinounion, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Positron Emission Tomography and Computed Tomography, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Positron Emission Tomography and Computed Tomography by region & country, by Type, and by Application.

The Positron Emission Tomography and Computed Tomography market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Positron Emission Tomography and Computed Tomography.

Market Segmentation

Report Metric
Details
Report Title
Positron Emission Tomography and Computed Tomography- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 5065 million
CAGR(2025-2031)
14.8%
Market Size Available for Years
2025-2031
Global Positron Emission Tomography and Computed Tomography Companies Covered
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical
Neusoft Medical
United Imaging
Arrays Medical
Minfound Medical
Sinounion
Global Positron Emission Tomography and Computed Tomography Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Positron Emission Tomography and Computed Tomography Market, Segment by Type
PMT
SIPM
Global Positron Emission Tomography and Computed Tomography Market, Segment by Application
Oncology
Cardiology
Neurology
Other
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Positron Emission Tomography and Computed Tomography manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Positron Emission Tomography and Computed Tomography in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Positron Emission Tomography and Computed Tomography in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Positron Emission Tomography and Computed Tomography Product Introduction
    1.2 Global Positron Emission Tomography and Computed Tomography Market Size Forecast
        1.2.1 Global Positron Emission Tomography and Computed Tomography Sales Value (2020-2031)
        1.2.2 Global Positron Emission Tomography and Computed Tomography Sales Volume (2020-2031)
        1.2.3 Global Positron Emission Tomography and Computed Tomography Sales Price (2020-2031)
    1.3 Positron Emission Tomography and Computed Tomography Market Trends & Drivers
        1.3.1 Positron Emission Tomography and Computed Tomography Industry Trends
        1.3.2 Positron Emission Tomography and Computed Tomography Market Drivers & Opportunity
        1.3.3 Positron Emission Tomography and Computed Tomography Market Challenges
        1.3.4 Positron Emission Tomography and Computed Tomography Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Positron Emission Tomography and Computed Tomography Players Revenue Ranking (2024)
    2.2 Global Positron Emission Tomography and Computed Tomography Revenue by Company (2020-2025)
    2.3 Global Positron Emission Tomography and Computed Tomography Players Sales Volume Ranking (2024)
    2.4 Global Positron Emission Tomography and Computed Tomography Sales Volume by Company Players (2020-2025)
    2.5 Global Positron Emission Tomography and Computed Tomography Average Price by Company (2020-2025)
    2.6 Key Manufacturers Positron Emission Tomography and Computed Tomography Manufacturing Base and Headquarters
    2.7 Key Manufacturers Positron Emission Tomography and Computed Tomography Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Positron Emission Tomography and Computed Tomography
    2.9 Positron Emission Tomography and Computed Tomography Market Competitive Analysis
        2.9.1 Positron Emission Tomography and Computed Tomography Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Positron Emission Tomography and Computed Tomography Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Positron Emission Tomography and Computed Tomography as of 2024)
    2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 PMT
        3.1.2 SIPM
    3.2 Global Positron Emission Tomography and Computed Tomography Sales Value by Type
        3.2.1 Global Positron Emission Tomography and Computed Tomography Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Positron Emission Tomography and Computed Tomography Sales Value, by Type (2020-2031)
        3.2.3 Global Positron Emission Tomography and Computed Tomography Sales Value, by Type (%) (2020-2031)
    3.3 Global Positron Emission Tomography and Computed Tomography Sales Volume by Type
        3.3.1 Global Positron Emission Tomography and Computed Tomography Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Positron Emission Tomography and Computed Tomography Sales Volume, by Type (2020-2031)
        3.3.3 Global Positron Emission Tomography and Computed Tomography Sales Volume, by Type (%) (2020-2031)
    3.4 Global Positron Emission Tomography and Computed Tomography Average Price by Type (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Oncology
        4.1.2 Cardiology
        4.1.3 Neurology
        4.1.4 Other
    4.2 Global Positron Emission Tomography and Computed Tomography Sales Value by Application
        4.2.1 Global Positron Emission Tomography and Computed Tomography Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Positron Emission Tomography and Computed Tomography Sales Value, by Application (2020-2031)
        4.2.3 Global Positron Emission Tomography and Computed Tomography Sales Value, by Application (%) (2020-2031)
    4.3 Global Positron Emission Tomography and Computed Tomography Sales Volume by Application
        4.3.1 Global Positron Emission Tomography and Computed Tomography Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Positron Emission Tomography and Computed Tomography Sales Volume, by Application (2020-2031)
        4.3.3 Global Positron Emission Tomography and Computed Tomography Sales Volume, by Application (%) (2020-2031)
    4.4 Global Positron Emission Tomography and Computed Tomography Average Price by Application (2020-2031)

5 Segmentation by Region
    5.1 Global Positron Emission Tomography and Computed Tomography Sales Value by Region
        5.1.1 Global Positron Emission Tomography and Computed Tomography Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Positron Emission Tomography and Computed Tomography Sales Value by Region (2020-2025)
        5.1.3 Global Positron Emission Tomography and Computed Tomography Sales Value by Region (2026-2031)
        5.1.4 Global Positron Emission Tomography and Computed Tomography Sales Value by Region (%), (2020-2031)
    5.2 Global Positron Emission Tomography and Computed Tomography Sales Volume by Region
        5.2.1 Global Positron Emission Tomography and Computed Tomography Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Positron Emission Tomography and Computed Tomography Sales Volume by Region (2020-2025)
        5.2.3 Global Positron Emission Tomography and Computed Tomography Sales Volume by Region (2026-2031)
        5.2.4 Global Positron Emission Tomography and Computed Tomography Sales Volume by Region (%), (2020-2031)
    5.3 Global Positron Emission Tomography and Computed Tomography Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        5.4.2 North America Positron Emission Tomography and Computed Tomography Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        5.5.2 Europe Positron Emission Tomography and Computed Tomography Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        5.6.2 Asia Pacific Positron Emission Tomography and Computed Tomography Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        5.7.2 South America Positron Emission Tomography and Computed Tomography Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        5.8.2 Middle East & Africa Positron Emission Tomography and Computed Tomography Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Value
        6.2.1 Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        6.3.2 United States Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Positron Emission Tomography and Computed Tomography Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        6.4.2 Europe Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Positron Emission Tomography and Computed Tomography Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        6.5.2 China Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Positron Emission Tomography and Computed Tomography Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        6.6.2 Japan Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Positron Emission Tomography and Computed Tomography Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        6.7.2 South Korea Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Positron Emission Tomography and Computed Tomography Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        6.8.2 Southeast Asia Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Positron Emission Tomography and Computed Tomography Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Positron Emission Tomography and Computed Tomography Sales Value, 2020-2031
        6.9.2 India Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Positron Emission Tomography and Computed Tomography Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 GE Healthcare
        7.1.1 GE Healthcare Company Information
        7.1.2 GE Healthcare Introduction and Business Overview
        7.1.3 GE Healthcare Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 GE Healthcare Positron Emission Tomography and Computed Tomography Product Offerings
        7.1.5 GE Healthcare Recent Development
    7.2 Siemens Healthcare
        7.2.1 Siemens Healthcare Company Information
        7.2.2 Siemens Healthcare Introduction and Business Overview
        7.2.3 Siemens Healthcare Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Siemens Healthcare Positron Emission Tomography and Computed Tomography Product Offerings
        7.2.5 Siemens Healthcare Recent Development
    7.3 Philips Healthcare
        7.3.1 Philips Healthcare Company Information
        7.3.2 Philips Healthcare Introduction and Business Overview
        7.3.3 Philips Healthcare Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Philips Healthcare Positron Emission Tomography and Computed Tomography Product Offerings
        7.3.5 Philips Healthcare Recent Development
    7.4 Canon Medical
        7.4.1 Canon Medical Company Information
        7.4.2 Canon Medical Introduction and Business Overview
        7.4.3 Canon Medical Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Canon Medical Positron Emission Tomography and Computed Tomography Product Offerings
        7.4.5 Canon Medical Recent Development
    7.5 Neusoft Medical
        7.5.1 Neusoft Medical Company Information
        7.5.2 Neusoft Medical Introduction and Business Overview
        7.5.3 Neusoft Medical Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Neusoft Medical Positron Emission Tomography and Computed Tomography Product Offerings
        7.5.5 Neusoft Medical Recent Development
    7.6 United Imaging
        7.6.1 United Imaging Company Information
        7.6.2 United Imaging Introduction and Business Overview
        7.6.3 United Imaging Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 United Imaging Positron Emission Tomography and Computed Tomography Product Offerings
        7.6.5 United Imaging Recent Development
    7.7 Arrays Medical
        7.7.1 Arrays Medical Company Information
        7.7.2 Arrays Medical Introduction and Business Overview
        7.7.3 Arrays Medical Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Arrays Medical Positron Emission Tomography and Computed Tomography Product Offerings
        7.7.5 Arrays Medical Recent Development
    7.8 Minfound Medical
        7.8.1 Minfound Medical Company Information
        7.8.2 Minfound Medical Introduction and Business Overview
        7.8.3 Minfound Medical Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 Minfound Medical Positron Emission Tomography and Computed Tomography Product Offerings
        7.8.5 Minfound Medical Recent Development
    7.9 Sinounion
        7.9.1 Sinounion Company Information
        7.9.2 Sinounion Introduction and Business Overview
        7.9.3 Sinounion Positron Emission Tomography and Computed Tomography Sales, Revenue, Price and Gross Margin (2020-2025)
        7.9.4 Sinounion Positron Emission Tomography and Computed Tomography Product Offerings
        7.9.5 Sinounion Recent Development

8 Industry Chain Analysis
    8.1 Positron Emission Tomography and Computed Tomography Industrial Chain
    8.2 Positron Emission Tomography and Computed Tomography Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Positron Emission Tomography and Computed Tomography Sales Model
        8.5.2 Sales Channel
        8.5.3 Positron Emission Tomography and Computed Tomography Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Positron Emission Tomography and Computed Tomography Market Trends
 Table 2. Positron Emission Tomography and Computed Tomography Market Drivers & Opportunity
 Table 3. Positron Emission Tomography and Computed Tomography Market Challenges
 Table 4. Positron Emission Tomography and Computed Tomography Market Restraints
 Table 5. Global Positron Emission Tomography and Computed Tomography Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Positron Emission Tomography and Computed Tomography Revenue Market Share by Company (2020-2025)
 Table 7. Global Positron Emission Tomography and Computed Tomography Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global Positron Emission Tomography and Computed Tomography Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Positron Emission Tomography and Computed Tomography Price by Company (2020-2025) & (US$/Unit)
 Table 10. Key Manufacturers Positron Emission Tomography and Computed Tomography Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Positron Emission Tomography and Computed Tomography Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Positron Emission Tomography and Computed Tomography
 Table 13. Global Positron Emission Tomography and Computed Tomography Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Positron Emission Tomography and Computed Tomography as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Positron Emission Tomography and Computed Tomography Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Positron Emission Tomography and Computed Tomography Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Positron Emission Tomography and Computed Tomography Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Positron Emission Tomography and Computed Tomography Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Positron Emission Tomography and Computed Tomography Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Positron Emission Tomography and Computed Tomography Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Positron Emission Tomography and Computed Tomography Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global Positron Emission Tomography and Computed Tomography Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global Positron Emission Tomography and Computed Tomography Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Positron Emission Tomography and Computed Tomography Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Positron Emission Tomography and Computed Tomography Price by Type (2020-2025) & (US$/Unit)
 Table 27. Global Positron Emission Tomography and Computed Tomography Price by Type (2026-2031) & (US$/Unit)
 Table 28. Global Positron Emission Tomography and Computed Tomography Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Positron Emission Tomography and Computed Tomography Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Positron Emission Tomography and Computed Tomography Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Positron Emission Tomography and Computed Tomography Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Positron Emission Tomography and Computed Tomography Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Positron Emission Tomography and Computed Tomography Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global Positron Emission Tomography and Computed Tomography Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global Positron Emission Tomography and Computed Tomography Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global Positron Emission Tomography and Computed Tomography Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Positron Emission Tomography and Computed Tomography Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Positron Emission Tomography and Computed Tomography Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global Positron Emission Tomography and Computed Tomography Price by Application (2026-2031) & (US$/Unit)
 Table 40. Global Positron Emission Tomography and Computed Tomography Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Positron Emission Tomography and Computed Tomography Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Positron Emission Tomography and Computed Tomography Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Positron Emission Tomography and Computed Tomography Sales Value by Region (2020-2025) & (%)
 Table 44. Global Positron Emission Tomography and Computed Tomography Sales Value by Region (2026-2031) & (%)
 Table 45. Global Positron Emission Tomography and Computed Tomography Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global Positron Emission Tomography and Computed Tomography Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global Positron Emission Tomography and Computed Tomography Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global Positron Emission Tomography and Computed Tomography Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Positron Emission Tomography and Computed Tomography Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Positron Emission Tomography and Computed Tomography Average Price by Region (2020-2025) & (US$/Unit)
 Table 51. Global Positron Emission Tomography and Computed Tomography Average Price by Region (2026-2031) & (US$/Unit)
 Table 52. Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Volume, (2026-2031) & (K Units)
 Table 57. GE Healthcare Company Information
 Table 58. GE Healthcare Introduction and Business Overview
 Table 59. GE Healthcare Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 60. GE Healthcare Positron Emission Tomography and Computed Tomography Product Offerings
 Table 61. GE Healthcare Recent Development
 Table 62. Siemens Healthcare Company Information
 Table 63. Siemens Healthcare Introduction and Business Overview
 Table 64. Siemens Healthcare Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. Siemens Healthcare Positron Emission Tomography and Computed Tomography Product Offerings
 Table 66. Siemens Healthcare Recent Development
 Table 67. Philips Healthcare Company Information
 Table 68. Philips Healthcare Introduction and Business Overview
 Table 69. Philips Healthcare Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. Philips Healthcare Positron Emission Tomography and Computed Tomography Product Offerings
 Table 71. Philips Healthcare Recent Development
 Table 72. Canon Medical Company Information
 Table 73. Canon Medical Introduction and Business Overview
 Table 74. Canon Medical Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Canon Medical Positron Emission Tomography and Computed Tomography Product Offerings
 Table 76. Canon Medical Recent Development
 Table 77. Neusoft Medical Company Information
 Table 78. Neusoft Medical Introduction and Business Overview
 Table 79. Neusoft Medical Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Neusoft Medical Positron Emission Tomography and Computed Tomography Product Offerings
 Table 81. Neusoft Medical Recent Development
 Table 82. United Imaging Company Information
 Table 83. United Imaging Introduction and Business Overview
 Table 84. United Imaging Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. United Imaging Positron Emission Tomography and Computed Tomography Product Offerings
 Table 86. United Imaging Recent Development
 Table 87. Arrays Medical Company Information
 Table 88. Arrays Medical Introduction and Business Overview
 Table 89. Arrays Medical Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Arrays Medical Positron Emission Tomography and Computed Tomography Product Offerings
 Table 91. Arrays Medical Recent Development
 Table 92. Minfound Medical Company Information
 Table 93. Minfound Medical Introduction and Business Overview
 Table 94. Minfound Medical Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Minfound Medical Positron Emission Tomography and Computed Tomography Product Offerings
 Table 96. Minfound Medical Recent Development
 Table 97. Sinounion Company Information
 Table 98. Sinounion Introduction and Business Overview
 Table 99. Sinounion Positron Emission Tomography and Computed Tomography Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Sinounion Positron Emission Tomography and Computed Tomography Product Offerings
 Table 101. Sinounion Recent Development
 Table 102. Key Raw Materials Lists
 Table 103. Raw Materials Key Suppliers Lists
 Table 104. Positron Emission Tomography and Computed Tomography Downstream Customers
 Table 105. Positron Emission Tomography and Computed Tomography Distributors List
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources


List of Figures
 Figure 1. Positron Emission Tomography and Computed Tomography Product Picture
 Figure 2. Global Positron Emission Tomography and Computed Tomography Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Positron Emission Tomography and Computed Tomography Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Positron Emission Tomography and Computed Tomography Sales Volume (2020-2031) & (K Units)
 Figure 5. Global Positron Emission Tomography and Computed Tomography Sales Price (2020-2031) & (US$/Unit)
 Figure 6. Positron Emission Tomography and Computed Tomography Report Years Considered
 Figure 7. Global Positron Emission Tomography and Computed Tomography Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Positron Emission Tomography and Computed Tomography Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Positron Emission Tomography and Computed Tomography Revenue in 2024
 Figure 10. Positron Emission Tomography and Computed Tomography Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. PMT Picture
 Figure 12. SIPM Picture
 Figure 13. Global Positron Emission Tomography and Computed Tomography Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Positron Emission Tomography and Computed Tomography Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Positron Emission Tomography and Computed Tomography Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 16. Global Positron Emission Tomography and Computed Tomography Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Positron Emission Tomography and Computed Tomography Price by Type (2020-2031) & (US$/Unit)
 Figure 18. Product Picture of Oncology
 Figure 19. Product Picture of Cardiology
 Figure 20. Product Picture of Neurology
 Figure 21. Product Picture of Other
 Figure 22. Global Positron Emission Tomography and Computed Tomography Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 23. Global Positron Emission Tomography and Computed Tomography Sales Value Market Share by Application, 2024 & 2031
 Figure 24. Global Positron Emission Tomography and Computed Tomography Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 25. Global Positron Emission Tomography and Computed Tomography Sales Volume Market Share by Application, 2024 & 2031
 Figure 26. Global Positron Emission Tomography and Computed Tomography Price by Application (2020-2031) & (US$/Unit)
 Figure 27. North America Positron Emission Tomography and Computed Tomography Sales Value (2020-2031) & (US$ Million)
 Figure 28. North America Positron Emission Tomography and Computed Tomography Sales Value by Country (%), 2024 VS 2031
 Figure 29. Europe Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 30. Europe Positron Emission Tomography and Computed Tomography Sales Value by Country (%), 2024 VS 2031
 Figure 31. Asia Pacific Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Positron Emission Tomography and Computed Tomography Sales Value by Region (%), 2024 VS 2031
 Figure 33. South America Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 34. South America Positron Emission Tomography and Computed Tomography Sales Value by Country (%), 2024 VS 2031
 Figure 35. Middle East & Africa Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 36. Middle East & Africa Positron Emission Tomography and Computed Tomography Sales Value by Country (%), 2024 VS 2031
 Figure 37. Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Value (%), (2020-2031)
 Figure 38. Key Countries/Regions Positron Emission Tomography and Computed Tomography Sales Volume (%), (2020-2031)
 Figure 39. United States Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 40. United States Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
 Figure 41. United States Positron Emission Tomography and Computed Tomography Sales Value by Application (%), 2024 VS 2031
 Figure 42. Europe Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 43. Europe Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
 Figure 44. Europe Positron Emission Tomography and Computed Tomography Sales Value by Application (%), 2024 VS 2031
 Figure 45. China Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 46. China Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
 Figure 47. China Positron Emission Tomography and Computed Tomography Sales Value by Application (%), 2024 VS 2031
 Figure 48. Japan Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 49. Japan Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
 Figure 50. Japan Positron Emission Tomography and Computed Tomography Sales Value by Application (%), 2024 VS 2031
 Figure 51. South Korea Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 52. South Korea Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
 Figure 53. South Korea Positron Emission Tomography and Computed Tomography Sales Value by Application (%), 2024 VS 2031
 Figure 54. Southeast Asia Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 55. Southeast Asia Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
 Figure 56. Southeast Asia Positron Emission Tomography and Computed Tomography Sales Value by Application (%), 2024 VS 2031
 Figure 57. India Positron Emission Tomography and Computed Tomography Sales Value, (2020-2031) & (US$ Million)
 Figure 58. India Positron Emission Tomography and Computed Tomography Sales Value by Type (%), 2024 VS 2031
 Figure 59. India Positron Emission Tomography and Computed Tomography Sales Value by Application (%), 2024 VS 2031
 Figure 60. Positron Emission Tomography and Computed Tomography Industrial Chain
 Figure 61. Positron Emission Tomography and Computed Tomography Manufacturing Cost Structure
 Figure 62. Channels of Distribution (Direct Sales, and Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed

Description

The global market for Positron Emission Tomography and Computed Tomography was estimated to be worth US$ 1953 million in 2024 and is forecast to a readjusted size of US$ 5065 million by 2031 with a CAGR of 14.8% during the forecast period 2025-2031.

Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its organs. It is suitable for whole body or local tumor examination, Cardiovascular system examination and brain nervous system examination. PET/CT can complete two image scans at the same time. PET images are molecular images of cell metabolism, showing the functional status of cells and organs, but cannot accurately locate the specific anatomical structure of diseased tissues. CT images are structural imaging, which can effectively display the anatomical structure of the human body. PET/CT combines the functional imaging of PET with the images of CT anatomical structure imaging, giving full play to their respective advantages, and has unique value in the qualitative and localization diagnosis of tumors, clinical staging, evaluation of curative effect, finding of metastases and monitoring of recurrence. .

North American market for Positron Emission Tomography and Computed Tomography was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Positron Emission Tomography and Computed Tomography was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Positron Emission Tomography and Computed Tomography was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Positron Emission Tomography and Computed Tomography include GE Healthcare, Siemens Healthcare, Philips Healthcare, Canon Medical, Neusoft Medical, United Imaging, Arrays Medical, Minfound Medical, Sinounion, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Positron Emission Tomography and Computed Tomography, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Positron Emission Tomography and Computed Tomography by region & country, by Type, and by Application.

The Positron Emission Tomography and Computed Tomography market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Positron Emission Tomography and Computed Tomography.

Market Segmentation

Related Reports

Positron Emission Tomography and Computed Tomography - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its organs. It is suitable for whole body or local tumor examination, Cardiovascular system examination and brain nervous system examination. PET/CT can complete two image scans at the same time. PET images are molecular images of cell metabolism, showing the functional status of cells and organs, but cannot accurately locate the specific anatomical structure of diseased tissues. CT images are structural imaging, which can effectively display the anatomical structure of the human body. PET/CT combines the functional imaging of PET with the images of CT anatomical structure imaging, giving full play to their respective advantages, and has unique value in the qualitative and localization diagnosis of tumors, clinical staging, evaluation of curative effect, finding of metastases and monitoring of recurrence. .
Published: 2024-02-19
Pages: 94
USD 3950.00
(Single User License)
Global Positron Emission Tomography and Computed Tomography Market Research Report 2024
Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its organs. It is suitable for whole body or local tumor examination, Cardiovascular system examination and brain nervous system examination. PET/CT can complete two image scans at the same time. PET images are molecular images of cell metabolism, showing the functional status of cells and organs, but cannot accurately locate the specific anatomical structure of diseased tissues. CT images are structural imaging, which can effectively display the anatomical structure of the human body. PET/CT combines the functional imaging of PET with the images of CT anatomical structure imaging, giving full play to their respective advantages, and has unique value in the qualitative and localization diagnosis of tumors, clinical staging, evaluation of curative effect, finding of metastases and monitoring of recurrence. .
Published: 2024-01-18
Pages: 84
USD 2900.00
(Single User License)
Global Positron Emission Tomography and Computed Tomography Market Insights, Forecast to 2030
Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its organs. It is suitable for whole body or local tumor examination, Cardiovascular system examination and brain nervous system examination. PET/CT can complete two image scans at the same time. PET images are molecular images of cell metabolism, showing the functional status of cells and organs, but cannot accurately locate the specific anatomical structure of diseased tissues. CT images are structural imaging, which can effectively display the anatomical structure of the human body. PET/CT combines the functional imaging of PET with the images of CT anatomical structure imaging, giving full play to their respective advantages, and has unique value in the qualitative and localization diagnosis of tumors, clinical staging, evaluation of curative effect, finding of metastases and monitoring of recurrence. .
Published: 2024-04-13
Pages: 86
USD 4900.00
(Single User License)
Global Positron Emission Tomography and Computed Tomography Market Research Report 2025
The global market for Positron Emission Tomography and Computed Tomography was valued at US$ 1953 million in the year 2024 and is projected to reach a revised size of US$ 5065 million by 2031, growing at a CAGR of 14.8% during the forecast period.
Published: 2025-02-14
Pages: 81
USD 2900.00
(Single User License)
Global Positron Emission Tomography and Computed Tomography Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Positron Emission Tomography and Computed Tomography market size was US$ 1953 million in 2024 and is forecast to a readjusted size of US$ 5065 million by 2031 with a CAGR of 14.8% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 76
USD 4250.00
(Single User License)
Global Positron Emission Tomography and Computed Tomography Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Positron Emission Tomography and Computed Tomography market is projected to grow from US$ 1953 million in 2024 to US$ 5065 million by 2031, at a CAGR of 14.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 141
USD 4900.00
(Single User License)
Global Positron Emission Tomography and Computed Tomography Market Research Report 2026
The global Positron Emission Tomography and Computed Tomography market was valued at US$ 2213 million in 2025 and is anticipated to reach US$ 5739 million by 2032, at a CAGR of 14.8% from 2026 to 2032.
Published: 2026-02-11
Pages: 116
USD 2900.00
(Single User License)
Positron Emission Tomography and Computed Tomography- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Positron Emission Tomography and Computed Tomography was estimated to be worth US$ 2213 million in 2025 and is projected to reach US$ 5739 million, growing at a CAGR of 14.8% from 2026 to 2032.
Published: 2026-02-11
Pages: 93
USD 3950.00
(Single User License)

Positron Emission Tomography and Computed Tomography - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its organs. It is suitable for whole body or local tumor examination, Cardiovascular system examination and brain nervous system examination. PET/CT can complete two image scans at the same time. PET images are molecular images of cell metabolism, showing the functional status of cells and organs, but cannot accurately locate the specific anatomical structure of diseased tissues. CT images are structural imaging, which can effectively display the anatomical structure of the human body. PET/CT combines the functional imaging of PET with the images of CT anatomical structure imaging, giving full play to their respective advantages, and has unique value in the qualitative and localization diagnosis of tumors, clinical staging, evaluation of curative effect, finding of metastases and monitoring of recurrence. .
Published: 2024-02-19
Pages: 94
USD 3950.00 ()
Global Positron Emission Tomography and Computed Tomography Market Research Report 2024
Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its organs. It is suitable for whole body or local tumor examination, Cardiovascular system examination and brain nervous system examination. PET/CT can complete two image scans at the same time. PET images are molecular images of cell metabolism, showing the functional status of cells and organs, but cannot accurately locate the specific anatomical structure of diseased tissues. CT images are structural imaging, which can effectively display the anatomical structure of the human body. PET/CT combines the functional imaging of PET with the images of CT anatomical structure imaging, giving full play to their respective advantages, and has unique value in the qualitative and localization diagnosis of tumors, clinical staging, evaluation of curative effect, finding of metastases and monitoring of recurrence. .
Published: 2024-01-18
Pages: 84
USD 2900.00 ()
Global Positron Emission Tomography and Computed Tomography Market Insights, Forecast to 2030
Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its organs. It is suitable for whole body or local tumor examination, Cardiovascular system examination and brain nervous system examination. PET/CT can complete two image scans at the same time. PET images are molecular images of cell metabolism, showing the functional status of cells and organs, but cannot accurately locate the specific anatomical structure of diseased tissues. CT images are structural imaging, which can effectively display the anatomical structure of the human body. PET/CT combines the functional imaging of PET with the images of CT anatomical structure imaging, giving full play to their respective advantages, and has unique value in the qualitative and localization diagnosis of tumors, clinical staging, evaluation of curative effect, finding of metastases and monitoring of recurrence. .
Published: 2024-04-13
Pages: 86
USD 4900.00 ()
Global Positron Emission Tomography and Computed Tomography Market Research Report 2025
The global market for Positron Emission Tomography and Computed Tomography was valued at US$ 1953 million in the year 2024 and is projected to reach a revised size of US$ 5065 million by 2031, growing at a CAGR of 14.8% during the forecast period.
Published: 2025-02-14
Pages: 81
USD 2900.00 ()
Global Positron Emission Tomography and Computed Tomography Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Positron Emission Tomography and Computed Tomography market size was US$ 1953 million in 2024 and is forecast to a readjusted size of US$ 5065 million by 2031 with a CAGR of 14.8% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 76
USD 4250.00 ()
Global Positron Emission Tomography and Computed Tomography Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Positron Emission Tomography and Computed Tomography market is projected to grow from US$ 1953 million in 2024 to US$ 5065 million by 2031, at a CAGR of 14.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 141
USD 4900.00 ()
Global Positron Emission Tomography and Computed Tomography Market Research Report 2026
The global Positron Emission Tomography and Computed Tomography market was valued at US$ 2213 million in 2025 and is anticipated to reach US$ 5739 million by 2032, at a CAGR of 14.8% from 2026 to 2032.
Published: 2026-02-11
Pages: 116
USD 2900.00 ()
Positron Emission Tomography and Computed Tomography- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Positron Emission Tomography and Computed Tomography was estimated to be worth US$ 2213 million in 2025 and is projected to reach US$ 5739 million, growing at a CAGR of 14.8% from 2026 to 2032.
Published: 2026-02-11
Pages: 93
USD 3950.00 ()